{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:46:22Z","timestamp":1761155182270,"version":"3.33.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[1986,9,1]],"date-time":"1986-09-01T00:00:00Z","timestamp":525916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1986,9,1]],"date-time":"1986-09-01T00:00:00Z","timestamp":525916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1986,9]]},"DOI":"10.1136\/ard.45.9.761","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"761-764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Neutropenia in patients with inflammatory arthritis treated with sulphasalazine."],"prefix":"10.1016","volume":"45","author":[{"given":"M","family":"Farr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.P","family":"Symmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.R","family":"Blake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.A","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/bmj.280.6212.442","article-title":"Sulphasalazine in rheumatoid arthritis","volume":"280","author":"McConkey, B.; S, Amos R.; Durham, S.; G, Forster P.J.; Hubball, S.; Walsh, L.","year":"1980","unstructured":"McConkey B, Amos R S, Durham S, Forster P J G, Hubball S, Walsh L. Sulphasalazine in rheumatoid arthritis. Br Med J 1980; 280: 442-4.","journal-title":"Br Med J"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/bmj.287.6399.1099","article-title":"Comparison betwcn penicillaminc and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial","volume":"287","author":"C, Neumann V.; A, Grindulis R.; B, Huball S.McConkey; V, Wright","year":"1983","unstructured":"Neumann V C, Grindulis R A, Huball S. McConkey B, Wright V. Comparison betwcn penicillaminc and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial. Br Med J 1983: 287: 1099-102.","journal-title":"Br Med J"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/bmj.287.6399.1102","article-title":"Sulphasalazinc in rheumatoid arthritis: a doublc hlind comparison of sulphasalazine with placebo and sodium aturothiomalate","volume":"287","author":"Pullar, T.; A, Hunter J.; A, Capell H.","year":"1983","unstructured":"Pullar T, Hunter J A, Capell H A. Sulphasalazinc in rheumatoid arthritis: a doublc hlind comparison of sulphasalazine with placebo and sodium aturothiomalate. Br Med J 1983; 287: 1102-4.","journal-title":"Br Med J"},{"issue":"473 8","key":"ref_4","first-page":"398","article-title":"The long telfll cfl'fcts of sulphasalazine in the trcatmncit of' hcielatoid arithiitis and at comparative study swith pcnicillamin","volume-title":"Outcomc ot' attcmlpts to treiat rheumltoid arthritis with gold. pcnicillamline. s1l.phasldazinc. or daipsonc. Aniii Rlieo, ni I)iS 1984: X 43","volume":"3","author":"A, FParr M.Tunni E.P.Crockson A.P.Biicon P.","year":"1984","unstructured":"FParr M. Tunni EP. Crockson A P. Biicon P A. The long telfll cfl'fcts of sulphasalazine in the trcatmncit of' hcielatoid arithiitis and at comparative study swith pcnicillamin. (Clin Rlweoouozzol 1984: 3: 473 8-. 5 Grindulis K A. McConkcs B. Outcomc ot' attcmlpts to treiat rheumltoid arthritis with gold. pcnicillamline. s1l.phasldazinc. or daipsonc. Aniii Rlieo,ni I)iS 1984:X 43: 398-401."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/ard.44.3.194","article-title":"Sulphasalazine: a safe effective agent for prolonged control of arthritis. A comparison with sodium aurothiomalate","volume":"44","author":"E, Bax D.; S, Amos R.","year":"1985","unstructured":"Bax D E, Amos R S. Sulphasalazine: a safe effective agent for prolonged control of arthritis. A comparison with sodium aurothiomalate. Anti Rheum Dis 1985; 44: 194-9.","journal-title":"Anti Rheum Dis"},{"key":"ref_6","first-page":"214","article-title":"Toxicity of sulphasalazine in patients with rheumatoid arthritis","volume":"XXIV:","author":"Pullar, T.; A, Hunter J.; A, Capell H.","year":"1985","unstructured":"Pullar T, Hunter J A, Capell H A. Toxicity of sulphasalazine in patients with rheumatoid arthritis. Br J Rheumatol 1985; XXIV: 214.","journal-title":"Br J Rheumatol"},{"key":"ref_7","first-page":"377","article-title":"Pharmacology, clinical use, toxicity and related new drug development","volume":"3","author":"Sulphasalazine, Peppercorn M.A.","year":"1984","unstructured":"Peppercorn M A. Sulphasalazine. Pharmacology, clinical use, toxicity and related new drug development. Ann Intern Med 1984; 3: 377-86.","journal-title":"Ann Intern Med"},{"key":"ref_8","first-page":"178","article-title":"Clinicail and pharmacological aspccts ol' sulphasalazinc. The Ncthcrlaltnds: Kiatholikc Untvcrsiteit tc Nijmcgcn","author":"van Hecs P A M","year":"1981","unstructured":"van Hecs P A M. Clinicail and pharmacological aspccts ol' sulphasalazinc. The Ncthcrlaltnds: Kiatholikc Untvcrsiteit tc Nijmcgcn. 1981): 178-X8). (MD thcsis)."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672412657X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672412657X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.45.9.761","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T06:01:07Z","timestamp":1737525667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672412657X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,9]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1986,9]]}},"alternative-id":["S000349672412657X"],"URL":"https:\/\/doi.org\/10.1136\/ard.45.9.761","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1986,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutropenia in patients with inflammatory arthritis treated with sulphasalazine.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.45.9.761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1986 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}